Sun Pharma is expected to post a 9% year-on-year revenue growth, supported by its US specialty portfolio and steady growth in chronic therapies in India.
Positive Breakout: Sanghvi Movers, Motherson Sumi among 10 stocks close cross above their 200 DMA
A total of 15 NSE-listed stocks with a market capitalisation of over Rs 1,000 crore closed above their 200-day moving average (DMA) as of August